Latest Innovation News

Page 54 of 359
Mesoblast is set to meet the FDA in December to discuss compelling Phase 3 data showing its cell therapy rexlemestrocel-L may significantly reduce opioid use in chronic low back pain patients. This meeting could mark a pivotal step in addressing the US opioid crisis through innovative regenerative medicine.
Ada Torres
Ada Torres
5 Nov 2025
EnergyX’s share price hike to US$11 signals renewed investor confidence and a lithium market rebound, increasing Pantera Lithium’s holding value by A$5.4 million.
Maxwell Dee
Maxwell Dee
5 Nov 2025
RAS Technology Holdings has landed a significant contract to provide racing data and managed trading services for LeoVegas Group’s UK brands, including BetMGM UK, marking a strategic expansion into regulated markets.
Sophie Babbage
Sophie Babbage
5 Nov 2025
FBR Limited has inked a non-binding Memorandum of Understanding with Fraser Lyne Constructions for the sale of a Hadrian® bricklaying robot unit valued at A$7.8 million, aiming to tackle New South Wales' housing shortage with advanced automation.
Sophie Babbage
Sophie Babbage
5 Nov 2025
ARC Funds Limited has strategically acquired $2.15 million face value of convertible notes in ausbiz TV at just 20% of their value, issuing 4.47 million new shares as consideration. This move aligns with ARC’s growth strategy to diversify income streams and deepen its investment platform.
Claire Turing
Claire Turing
5 Nov 2025
Impact Minerals is reigniting exploration at its vast Broken Hill project in NSW, leveraging rising metal prices and a proprietary multi-metal ratio to uncover high-grade platinum group metals and base metals.
Maxwell Dee
Maxwell Dee
5 Nov 2025
ReNerve Limited is scaling up its clinical trial for the NervAlign® Nerve Cuff following promising interim results that show significant pain reduction in nerve repair patients. The expanded study aims to solidify evidence for broader regulatory approval and market adoption.
Ada Torres
Ada Torres
5 Nov 2025
Tryptamine Therapeutics has raised $6.1 million to fast-track clinical development of its IV-infused psilocin drug TRP-8803, targeting binge eating disorder and other neuropsychiatric conditions.
Ada Torres
Ada Torres
5 Nov 2025
Nanosonics Limited has announced a $20 million on-market share buy-back program for FY26, underscoring its robust financial health and confidence in future growth driven by new product innovations.
Ada Torres
Ada Torres
5 Nov 2025
Great Dirt Resources has reported rock chip assays revealing manganese grades up to 51.8% at its Basin and Neranghi projects in NSW, underpinning a promising new deposit model and advanced geophysical research.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Kinetiko Energy has secured the first tranche of funding from FFS Refiners to accelerate development of a pilot LNG gas plant at Brakfontein, marking a key step in its multi-phase Project Alpha.
Maxwell Dee
Maxwell Dee
5 Nov 2025
Green Critical Minerals has signed a landmark MoU with South Korea’s Komex Carbon Corporation to co-develop and commercialize Very High Density (VHD) carbon products, marking GCM’s first international commercial agreement and a key step toward revenue generation in 2026.
Sophie Babbage
Sophie Babbage
5 Nov 2025